NF1 microdeletion patients, therefore, represent a high-risk group forthe development of MPNSTs, tumours which are very aggressive and difficult to treat.Co-deletion of the SUZ12 gene in addition toNF1 further increases the MPNST risk inNF1 microdeletion patients. This evidence concerns the gene SUZ12 and malignant peripheral nerve sheath tumor.